Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review

References

• Ito Y, Miyauchi A. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J. 2009;56:177–192.
   PubMed Web of Science ®Google Scholar
• Takebe K, Date M, Yamamoto N. Mass screening for thyroid cancer with ultrasonography. KARKINOS. 1994;7:309–317.
   Google Scholar
• Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid. 2018;28:23–31.
   PubMed Web of Science ®Google Scholar
• Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2018;40:516–522.
   Web of Science ®Google Scholar
• Takami H, Ito Y, Okamoto T, et al. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg. 2011;35:111–121.
   PubMed Web of Science ®Google Scholar
• Japanese Society of Thyroid Surgery, Japan Association of Endocrine Surgeons. Guidelines for the management of thyroid tumors. 2nd ed. Tokyo; 2018.
   Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140:317–322.
   PubMed Web of Science ®Google Scholar
• Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med. 2014;371:1765–1767.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Franceschi W, Bray F, et al. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614–617.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Oda H, et al. Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? World J Surg. 2016;40:523–528.
   PubMed Web of Science ®Google Scholar
• Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381–387.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27–34.
   PubMed Web of Science ®Google Scholar
• Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34:1222–1231.
   PubMed Web of Science ®Google Scholar
• Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26:150–155.
   PubMed Web of Science ®Google Scholar
• Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26:144–149.
   PubMed Web of Science ®Google Scholar
• Tuttle RM, Fagin JA, Minkowitz G, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143:1015–1020.
   PubMed Web of Science ®Google Scholar
• Kwon H, Oh HS, Kim M, et al. Active surveillance for patients with papillary thyroid microcarcinoma: a single center’s experience in Korea. J Clin Endocrinol Metab. 2017;102:1917–1925.
   PubMed Web of Science ®Google Scholar
• Oh HS, Ha J, Kim HI, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid. 2018;28:1587–1594.
   PubMed Web of Science ®Google Scholar
• Sanabria A. Active surveillance in thyroid microcarcinoma in a Latin-American cohort. JAMA Otolaryngol Head Neck Surg. 2018;144:947–948.
   PubMed Web of Science ®Google Scholar
• Smulever A, Pitoia F. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Arch Endocrinol Metab. 2019;63:462–469.
   PubMed Web of Science ®Google Scholar
• Molinaro E, Campopiano MC, Peruzzi L, et al. Active surveillance in papillary thyroid microcarcinoma is feasible and safe: experience at one Italian single center. J Clin Endocrinol Metab. 2019 Dec 7. DOI:10.1210/clinem/dgz113
   Web of Science ®Google Scholar
• Oh HS, Kwon H, Song E, et al. Tumor volume doubling time in active surveillance of papillary thyroid carcinoma. Thyroid. 2019;29:642–649.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Kudo T, Ito Y, et al. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery. 2018;163:48–52.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Kudo T, Miya A, et al. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid. 2011;21:707–716.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Kudo T, Ito Y, et al. Natural history of papillary thyroid microcarcinoma: kinetic analyses on tumor volume during active surveillance and before presentation. Surgery. 2019;165:25–30.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kudo T, et al. Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma hospital. Thyroid. 2016;26:156–160.
   PubMed Web of Science ®Google Scholar
• Fukuoka O, Sugitani I, Ebina A, et al. Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance. World J Surg. 2016;40:529–537.
   PubMedGoogle Scholar
• Oda H, Miyauchi A, Ito Y, et al. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J. 2017;64:59–64.
   PubMed Web of Science ®Google Scholar
• Lang BH, Wong CK. A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma. Eur J Endocrinol. 2015;173:367–375.
   PubMed Web of Science ®Google Scholar
• Venkatesh S, Pasternak JD, Beninato T, et al. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer. Surgery. 2017;161:116–126.
   PubMed Web of Science ®Google Scholar
• Sugitani I, Fujimoto Y, Yamada K. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg. 2014;38:673–678.
   PubMed Web of Science ®Google Scholar
• Kim HI, Jang HW, Ahn HS, et al. High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance. J Clin Endocrinol Metab. 2018;103:446–451.
   PubMed Web of Science ®Google Scholar
• Nickel B, Brito JP, Barratt A, et al. Clinicians’ views on management and terminology for papillary thyroid microcarcinoma: a qualitative study. Thyroid. 2017;27:661–671.
   PubMed Web of Science ®Google Scholar
• Nickel B, Brito JP, Moynihan R, et al. Patients’ experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study. BMC Cancer. 2018;18:242.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kudo T, et al. Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at Kuma hospital: gradual increase and heterogeneity in the acceptance of this new management option. Thyroid. 2018;28:488–495.
   PubMed Web of Science ®Google Scholar
• Davies L, Roman BR, Fukushima M, et al. Patient experience of thyroid cancer active surveillance in Japan. JAMA Otolaryngol Head Neck Surg. 2019;145:363–370.
   PubMed Web of Science ®Google Scholar
• Brito JP, Moon JH, Zeuren R, et al. Thyroid cancer treatment choice: a pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options. Thyroid. 2018;28:1325–1331.
   PubMed Web of Science ®Google Scholar
• Jeon MJ, Lee YM, Sung TY, et al. Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study. Thyroid. 2019;29:956–962.
   PubMed Web of Science ®Google Scholar
• Hirokawa M, Kudo T, Ota H, et al. Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J. 2016;63:805–810.
   PubMed Web of Science ®Google Scholar
• Yabuta T, Matsuse M, Hirokawa M, et al. TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance. Thyroid. 2017;27:1206–1207.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Ito Y. Conservative surveillance management of low-risk papillary thyroid microcarcinoma. Endocrinol Metab Clin North Am. 2019;48:215–226.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A. Active surveillance as first-line management of papillary microcarcinoma. Ann Rev Med. 2019;70:369–379.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol. 2018;44:307–315.
   PubMed Web of Science ®Google Scholar